R619-M68-303: CMV51p> TPAss-SARS-CoV-2 S-RBD(319-529)-3C-His8-SBP Citations (2)

Originally described in: Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays.
Mehalko J, Drew M, Snead K, Denson JP, Wall V, Taylor T, Sadtler K, Messing S, Gillette W, Esposito D Protein Expr Purif. 2021 Mar;179:105802. doi: 10.1016/j.pep.2020.105802. Epub 2020 Nov 25. PubMed Journal

---

Articles Citing R619-M68-303: CMV51p> TPAss-SARS-CoV-2 S-RBD(319-529)-3C-His8-SBP

Articles
Refining the N-Termini of the SARS-CoV-2 Spike Protein and Its Discrete Receptor-Binding Domain. D'Ippolito RA, Drew MR, Mehalko J, Snead K, Wall V, Putman Z, Esposito D, DeHart CJ. J Proteome Res. 2021 Sep 3;20(9):4427-4434. doi: 10.1021/acs.jproteome.1c00349. Epub 2021 Aug 11. PubMed
SARS-CoV-2 Seroprevalence and Drug Use in Trauma Patients from Six Sites in the United States. Ngo TB, Karkanitsa M, Adusei KM, Graham LA, Ricotta EE, Darrah JR, Blomberg RD, Spathies J, Pauly KJ, Klumpp-Thomas C, Travers J, Mehalko J, Drew M, Hall MD, Memoli MJ, Esposito D, Kozar RA, Griggs C, Cunningham KW, Schulman CI, Crandall M, Neavyn M, Dorfman JD, Lai JT, Whitehill JM, Babu KM, Mohr NM, Van Heukelom J, Fell JC, Rooke W, Kalish H, Thomas FD, Sadtler K. medRxiv. 2021 Aug 11. doi: 10.1101/2021.08.10.21261849. PubMed

If you have published an article using this material, please email us at to have your article added to this page.